Albany, NY -- (SBWire) -- 06/01/2018 --Based on drug agent, the global Ocular Diagnostic Agents Market can be segmented into fluorescein dye, rose Bengal stain, trypan blue, and others. The fluorescein dye segment is likely to expand at a significant pace during the forecast period, as the dye more effectively helps in performing angiography or angioscopy of the retina and the iris as compared to other dyes or agents.
Additionally, fluorescein dye is available in the form of drops and strips, which makes its use in diagnostics very convenient for physicians. In terms of indication, the global ocular diagnostic agents market can be classified into ophthalmic diagnosis and ophthalmic surgery. The diagnosis segment is expected to expand at a rapid pace during the forecast period, as more number of patients are involved in the ophthalmic diagnosis compared to surgery. In terms of distribution channel, the global ocular diagnostic agents market can be segmented into hospital pharmacies and medical stores. The hospital pharmacies segment is likely to expand at a significant pace during the forecast period, as most ophthalmic diagnoses and surgeries are performed in hospitals.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43409
Increase in the prevalence of dry eye along with inflammation of the ocular surface, especially among elderly people, is one of the major factors fueling the global ocular diagnostic agents market. Moreover, rise in the prevalence of age-related macular degeneration (AMD) and environmental factors such as central heating, air pollution, and chemical burns affecting the tear film leading to eye infection are projected to drive the market during the forecast period. However, high costs associated with ophthalmic diagnosis and adverse reactions of ocular diagnostic agents such as transient nausea and occasional vomiting are likely to hamper the market in the next few years.
Key players operating in the global ocular diagnostic agents market are Akorn, Incorporated, Nomax, Inc., HUB Pharmaceuticals LLC, Alcon Laboratories, Inc., and Altaire Pharmaceuticals.
Enquiry for discount on this report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=43409
Ocular Diagnostic Agents Market Poised to Garner Maximum Revenues by 2026